← Leaderboards
Stephen Whitehead
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusClinical TrialsClinical ResearchVaccine CandidateVaccinesAttenuatedFlavivirusImmune ResponseImmunogenicityEvaluationVaccinationAdmixtureDengue VaccineDengue VirusDengueAttenuated VaccinesDoseSafetyAge GroupAreaChildNational Institute Of Allergy And Infectious DiseaseProgramsThailand
Grant awards (31)
Laboratory And Preclinical Studies Of Flaviviruses$1,070,401
ZIA · FY2025 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$356,801
ZIA · FY2025 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$3,063,895
ZIA · FY2024 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$1,196,438
ZIA · FY2024 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$16,391
ZIA · FY2024 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$1,152,046
ZIA · FY2023 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$500,891
ZIA · FY2023 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$16,697
ZIA · FY2023 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$1,048,261
ZIA · FY2022 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$455,767
ZIA · FY2022 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$15,193
ZIA · FY2022 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$966,422
ZIA · FY2021 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$505,513
ZIA · FY2021 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$14,869
ZIA · FY2021 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$1,057,919
ZIA · FY2020 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$769,397
ZIA · FY2020 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$96,176
ZIA · FY2020 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$1,078,623
ZIA · FY2019 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$784,454
ZIA · FY2019 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$98,058
ZIA · FY2019 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$1,926,128
ZIA · FY2018 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$908,864
ZIA · FY2018 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$82,624
ZIA · FY2018 · AI · contact PI
Clinical Trials of Biodefense Vaccines (Dengue)$1,282,189
ZIA · FY2017 · AI · contact PI
Laboratory And Preclinical Studies Of Flaviviruses$456,567
ZIA · FY2017 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$65,224
ZIA · FY2017 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$63,465
ZIA · FY2016 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$70,438
ZIA · FY2015 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$118,949
ZIA · FY2014 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$128,537
ZIA · FY2013 · AI · contact PI
CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity$131,844
ZIA · FY2012 · AI · contact PI